| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/11/2011 | EP2319515A1 Coccidicide combination for veterinary use |
| 05/11/2011 | EP2319514A1 Stable aqueous solution composition containing sulfonamide compound |
| 05/11/2011 | EP2319510A1 Benzoyl peroxide composition for treating skin |
| 05/11/2011 | EP2319503A2 Drug delivery carrier |
| 05/11/2011 | EP2319502A1 Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/11/2011 | EP2319496A1 Pharmaceutical preparation containing oxycodone and naloxone |
| 05/11/2011 | EP2319494A1 Pharmaceutical compositions for the treatment of asthma |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2319489A2 Oral care composition comprising ovomucin and mannoprotein |
| 05/11/2011 | EP2318422A2 Hydrophobically enhanced aminoglycosides |
| 05/11/2011 | EP2318050A2 Factor viii polymer conjugates |
| 05/11/2011 | EP2318026A2 Composition for controlling increase in blood glucose |
| 05/11/2011 | EP2317993A2 Methods of administering topical antifungal formulations for the treatment of fungal infections |
| 05/11/2011 | EP2317990A2 Microparticulate oral drug form useful for the modified release of nanoparticles |
| 05/11/2011 | EP2317989A2 Microparticles |
| 05/11/2011 | EP2317984A1 Articles of manufacture releasing an active ingredient |
| 05/11/2011 | EP2317978A2 Stable injectable oil-in-water docetaxel nanoemulsion |
| 05/11/2011 | EP2317977A2 Pharmaceutical composition having relatively low ionic strength |
| 05/11/2011 | EP2317975A1 Octreotide implant having a release agent |
| 05/11/2011 | EP2317847A1 Selective inhibition of polyglutamine protein expression |
| 05/11/2011 | EP2092069B1 Modified soluble fgf receptor fc fusions with improved biological activity |
| 05/11/2011 | EP1900368B1 Tablet containing hardly soluble active ingredient |
| 05/11/2011 | EP1725271B1 Method for deactivating nucleic acids |
| 05/11/2011 | EP1672025B1 Finely particulate composite containing carbon compound encapsulated therein |
| 05/11/2011 | EP1651308B1 Implantable stimulation electrode with a coating for increasing tissue compatibility |
| 05/11/2011 | EP1458360B1 Pulmonary delivery of aminoglycosides |
| 05/11/2011 | EP1453916B1 Combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
| 05/11/2011 | EP0876109B2 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 05/11/2011 | CN1852740B Multi-arm polymer prodrugs |
| 05/11/2011 | CN1658823B Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 05/11/2011 | CN102056615A Compositions of peptides and processes of preparation thereof |
| 05/11/2011 | CN102056610A Fine granules having improved suspension performance in water |
| 05/11/2011 | CN102056599A Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 05/11/2011 | CN102056598A Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 05/11/2011 | CN102056590A Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 05/11/2011 | CN102051702A Mesoporous silicon oxide particle/degradable polymer nano composite fiber, preparation method and application thereof |
| 05/11/2011 | CN102051016A Degradable amphiphilic triblock copolymer micelle and preparation method and application of degradable amphiphilic triblock copolymer micelle |
| 05/11/2011 | CN102050953A Method for preparing reducible and degradable supermolecule hydrogel |
| 05/11/2011 | CN102049051A Medicinal composition for stabilizing pholcodine granules |
| 05/11/2011 | CN102049045A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 05/11/2011 | CN102049042A Novel oral compound capsule preparation for treating diabetes and obesity |
| 05/11/2011 | CN102049040A Artificial surface-active substance mixed liquid as well as preparation and application thereof |
| 05/11/2011 | CN102049038A Application of gelatinase A inhibitory polypeptide modifier |
| 05/11/2011 | CN102049007A Medical anti-inflammatory and anti-toxic external cream and preparation method thereof |
| 05/11/2011 | CN102048953A Traditional Chinese medicine composition for hyperplasia of mammary glands and preparation method of hydrogel patch thereof |
| 05/11/2011 | CN102048925A TCM plaster used for coaptation |
| 05/11/2011 | CN102048912A Pills for treating rheumatism and rheumatoid arthritis and preparation method thereof |
| 05/11/2011 | CN102048889A Formula of instant effervescent tablets prepared from Chinese medicinal herbs |
| 05/11/2011 | CN102048860A Nasosinusitis soft capsule pharmaceutical preparation and preparation method thereof |
| 05/11/2011 | CN102048843A Qingpeng emplastrum for reducing swelling and stopping pain and preparation method thereof |
| 05/11/2011 | CN102048828A Biond magnolia flower oil capsules for treating rhinitis and preparation process thereof |
| 05/11/2011 | CN102048819A Chinese medicinal pills and preparation method thereof |
| 05/11/2011 | CN102048816A Chinese medicinal double-layer patch for treating oral ulcer and preparation method thereof |
| 05/11/2011 | CN102048813A Ziziphora bungeana dripping pills, production method thereof and application of dripping pills as cardiovascular medicament |
| 05/11/2011 | CN102048793A Bee glue and honeysuckle lozenge |
| 05/11/2011 | CN102048784A Spray for treating rhinitis and preparation method thereof |
| 05/11/2011 | CN102048776A Gelata for treating gynecologic inflammation and preparation method thereof |
| 05/11/2011 | CN102048768A Preparation method of Naoqing nasal spray emulsion for treating ischemic stroke |
| 05/11/2011 | CN102048765A Method for preventing traditional Chinese medicinal extract powder from absorbing moisture and blocking |
| 05/11/2011 | CN102048762A Enteric coated pellet with leech as raw material |
| 05/11/2011 | CN102048739A Cefradine/montmorillonite composite material and preparation method thereof |
| 05/11/2011 | CN102048736A Dasatinib pharmaceutical composition and preparation method thereof |
| 05/11/2011 | CN102048734A Pharmaceutical composition |
| 05/11/2011 | CN102048725A Taxol-cholesterin complex |
| 05/11/2011 | CN102048723A Acid containing oxaliplatin formulations |
| 05/11/2011 | CN102048719A Agomelatine medicinal composition |
| 05/11/2011 | CN102048717A Stable rasagiline composition |
| 05/11/2011 | CN102048713A 透皮治疗系统 Transdermal therapeutic system |
| 05/11/2011 | CN102048710A Quickly dissolved film and preparation method thereof |
| 05/11/2011 | CN102048709A Gentamycin sulfate capsule and preparation method thereof |
| 05/11/2011 | CN102048706A Darifenacin hydrobromide sustained-release tablet and preparation method |
| 05/11/2011 | CN102048705A Palonosetron hydrochloride orally disintegrating tablet and preparation method thereof |
| 05/11/2011 | CN102048704A Levofloxacin lactate dispersible tablet and preparation method thereof |
| 05/11/2011 | CN102048703A Gatifloxacin dispersible tablets and preparation method thereof |
| 05/11/2011 | CN102048700A Colon targeted preparation of semi-pinnated brake herb extract 5F and preparation method thereof |
| 05/11/2011 | CN102048699A Preparation method for sustained release microsphere of injection triptorelin acetate |
| 05/11/2011 | CN102048698A Streptomycin sulfate albumin microspheres and preparation method |
| 05/11/2011 | CN102048697A Method for preparing solid lipid nanoparticles of water-soluble anti-tumor medicine |
| 05/11/2011 | CN102048696A Preparation method of lipid nanoparticles |
| 05/11/2011 | CN102048695A Preparation method of protein nanoparticle for in vivo delivery of pharmacologically active agent |
| 05/11/2011 | CN102048694A Polypeptide-modified liver tumor-targeted nano medicine delivery system and preparation method thereof |
| 05/11/2011 | CN102048693A Liposome having internal aqueous phases of benzenesulfonic acid derivatives |
| 05/11/2011 | CN102048690A Dimeticone emulsion and preparation method thereof |
| 05/11/2011 | CN102048689A Bioadhesive drug delivery system |
| 05/11/2011 | CN102048688A Taxol submicroemulsion taking cholesterol complex as intermediate carrier |
| 05/11/2011 | CN102048687A Preparation method for alprostadil injection |
| 05/11/2011 | CN102048685A Pefloxacin mesylate injection and preparation method and application thereof |
| 05/11/2011 | CN102048684A Method for preparing rocuronium bromide injection |
| 05/11/2011 | CN102048683A Lentinan injection and preparation method thereof |
| 05/11/2011 | CN102048680A Enteric sustained-release preparation containing zaltoprofen and preparation method thereof |
| 05/11/2011 | CN102048679A Transdermal preparation containing silodosin, preparation method and medicinal application thereof |
| 05/11/2011 | CN102048678A Transdermal absorption preparation of oxybutynin as well as preparation method and medication application thereof |
| 05/11/2011 | CN102048677A Valganciclovir Hydrochloride solid preparation and preparation method thereof |
| 05/11/2011 | CN101703489B Entecavir soft capsule |
| 05/11/2011 | CN101664512B Method for preparing traditional Chinese medicine preparation containing herba sarcandrae extracts |
| 05/11/2011 | CN101606907B Fotemustine solid lipid nanoparticle and preparation method thereof |
| 05/11/2011 | CN101565469B Acid amide-grafted sodium alginate nanometer material, preparation method thereof and use thereof |
| 05/11/2011 | CN101554367B Method for preparing sulfhydryl carboxymethyl chitosan microgel applicable to mucosa delivery |
| 05/11/2011 | CN101537191B Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |